Alan Menter, MD, discusses best practices in establishing disease severity in patients with plaque psoriasis, the efficacy and safety of established and newly approved systemic therapies for treating patients with moderate-to-severe disease, and how to optimize treatment for patients with chronic plaque psoriasis.
Discover the foremost questions dermatologists have about moderate-to-severe plaque psoriasis.
Probe details of a related patient case.
This activity was developed for dermatologists, dermatology fellows, advanced nurse practitioners, physician assistants and other health care professionals who have an interest in moderate-to-severe plaque psoriasis.
1.00 AMA PRA Category 1 Credit™.
1.00 AANP Contact Hour
1.00 ANCC Contact Hour
|Opens:||September 29, 2017|
|Expires:||September 28, 2018|
Other Health Care Providers